Laboratory powder diffraction is a proven and trusted technique for pharma R&D, but synchrotron powder diffraction pushes beyond the capabilities of conventional instrumentation. SPS-XRPD-3 will highlight the most exciting recent developments and opportunities in pharmaceutical R&D made possible by synchrotron XRPD. The meeting offers the chance to engage an active network of synchrotron, academic Read more
WEST LAFAYETTE, IND. (PRWEB) DECEMBER 26, 2019 2019 was another great year for Improved Pharma LLC, highlighted by a highly successful AAPS meeting and several internal advances in our problem-solving capabilities. At the AAPS, the Improved Pharma booth was grouped with other formulation companies and was able to establish several contacts and initial collaborations. Improved Pharma was Read more
WEST LAFAYETTE, IND. (PRWEB) DECEMBER 23, 2019 Detecting a small amount of a crystalline component in a predominantly amorphous material is relatively straight-forward, but the reverse situation can be quite daunting. Over the years, several methodologies have been developed to address this challenge. Below, Improved Pharma describes some of these approaches and announces advances of their Read more
WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 24, 2019 Improved Pharma LLC will be presenting their latest research in the area of high-level X-ray methods using synchrotron-produced X-rays to study amorphous drug formulations. On Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present “Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: A Read more
WEST LAFAYETTE, IND. (PRWEB) AUGUST 29, 2019 Prof. Stephen R. Byrn travels to Africa several times a year to teach in the Sustainable Medicines in Africa program, which includes a master’s degree in biotechnology innovation and regulatory science. The next course will take place in Arusha, Tanzania September 2nd through 13th, 2019. Topics to be Read more
WEST LAFAYETTE, IND. (PRWEB) JULY 19, 2019 Improved Pharma LLC announces the upcoming presentation of “Continuity of Solids between Amorphous and Crystalline States – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The authors are Stephen R. Byrn and Pamela A. Smith of Improved Pharma, along with Chris Benmore of Argonne National Laboratory and Gabriel de Read more
DOWNLOAD THIS WHITE PAPER AS A PDF BY CLICKING ON THIS LINK The abuse and misuse of prescription opioid products is a serious and growing public health problem. Opioid products are often manipulated to bypass extended-release (ER) properties. As such, the FDA is encouraging the development of opioid formulations that are more difficult to abuse Read more
May is speed month here in Indiana, home of the Indy 500. Improved Pharma is celebrating speed month by highlighting services that help you speed your drug development and reduce time to market. Importantly, it is Improved Pharma’s expertise and scientific knowledge that is the key to faster, cheaper drug development. We have a range Read more
Improved Pharma LLC will be exhibiting in booth 551, conveniently located in the center of the Formulation and Quality section next to one of the Poster Forums. We look forward to meeting with you to discuss the latest advances in pharmaceutical research and development. Have a problem with solubility or bioavailability? Want to reformulate your Read more
Laboratory powder diffraction is a proven and trusted technique for pharma R&D but synchrotron powder diffraction pushes beyond the capabilities of conventional instrumentation. SPS-XRPD is joining with PPXRD to highlight the most exciting recent developments and opportunities in pharmaceutical R&D made possible by synchrotron XRPD. The joint meeting offers the chance to engage an active Read more
